Greenwich LifeSciences, Inc.

NasdaqCM:GLSI Rapporto sulle azioni

Cap. di mercato: US$194.5m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Greenwich LifeSciences Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Snehal Patel

Amministratore delegato

US$2.8m

Compenso totale

Percentuale dello stipendio del CEO20.2%
Mandato del CEO14.5yrs
Proprietà del CEO42.1%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione14.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

Aug 22
We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

Greenwich LifeSciences: Trying To Move A Needle That Doesn't Like To Budge

Jun 26

Here's Why We're Not Too Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Situation

Jan 12
Here's Why We're Not Too Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Situation

We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Jan 29
We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Greenwich LifeSciences: Persevering CEO And Interesting Data

Sep 06

Greenwich LifeSciences halts stock buyback program

Jul 11

Greenwich LifeSciences: A First Look

May 19

Greenwich LifeSciences: Insider Buying And Buybacks Telegraph This Company's Vast Potential

Apr 21

Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth

Feb 01
Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth

We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

Sep 30
We Think Greenwich LifeSciences (NASDAQ:GLSI) Can Afford To Drive Business Growth

We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Apr 04
We're Not Very Worried About Greenwich LifeSciences' (NASDAQ:GLSI) Cash Burn Rate

Are Insiders Buying Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock?

Feb 16
Are Insiders Buying Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock?

What Is The Ownership Structure Like For Greenwich LifeSciences, Inc. (NASDAQ:GLSI)?

Dec 25
What Is The Ownership Structure Like For Greenwich LifeSciences, Inc. (NASDAQ:GLSI)?

Greenwich LifeSciences: Optimism On 'GP2' Breast Cancer Immunotherapy Candidate

Dec 23

Greenwich LifeSciences under stress on pricing upsized $26.4M equity offering

Dec 18

Greenwich LifeSciences inks deal with Westport Bio for pre-clinical coronavirus vaccine candidates

Dec 15

Greenwich LifeSciences trebles in value as breast cancer therapy shines in mid-stage trial

Dec 09

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Snehal Patel rispetto agli utili di Greenwich LifeSciences?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$10m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023US$3mUS$557k

-US$9m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$9m

Mar 31 2023n/an/a

-US$8m

Dec 31 2022US$2mUS$506k

-US$8m

Sep 30 2022n/an/a

-US$7m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$1mUS$450k

-US$5m

Sep 30 2021n/an/a

-US$3m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$2m

Dec 31 2020US$999kUS$115k

-US$2m

Sep 30 2020n/an/a

-US$1m

Jun 30 2020n/an/a

-US$1m

Mar 31 2020n/an/a

-US$4m

Dec 31 2019US$139kn/a

-US$3m

Compensazione vs Mercato: La retribuzione totale di Snehal ($USD 2.75M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.54M ).

Compensazione vs guadagni: La retribuzione di Snehal è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Snehal Patel (60 yo)

14.5yrs

Mandato

US$2,750,029

Compensazione

Mr. Snehal S. Patel has been Chief Executive Officer of Greenwich Lifesciences Inc. since June 2016 and has been Chief Financial Officer and Director since February 2010. He serves as Managing Director at...


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Snehal Patel
CEO, CFO & Director14.5yrsUS$2.75m42.11%
$ 81.9m
Eric Rothe
Founder & Independent Director18yrsUS$65.64k2.38%
$ 4.6m
Frank Daugherty
Chief Medical Officer & Director4.9yrsNessun dato0.69%
$ 1.3m
David McWilliams
Independent Chairman of the Board15.5yrsUS$98.39k4.72%
$ 9.2m
Kenneth Hallock
Independent Director4.9yrsUS$65.64k3.02%
$ 5.9m

14.5yrs

Durata media

73yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di GLSI è composto da personale esperto e esperto (durata media dell'incarico 14.5 anni).